Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: A longitudinal T2 relaxometry pilot study

We used magnetic resonance imaging to examine the effect of ethyl-eicosapentaenoic acid (E-EPA) on hippocampal T(2) relaxation time in first episode psychosis patients at baseline and after 12 weeks of follow-up. There was an increase in T(2) in the placebo group but not in the E-EPA group, suggesting a neuroprotective effect of E-EPA treatment. In addition, the smaller the increase in T(2), the greater the improvement in negative symptoms.

[1]  A. Stoll,et al.  Omega-3 Fatty Acid Treatment and T2 Whole Brain Relaxation Times in Bipolar Disorder , 2004 .

[2]  Jeffrey K. Yao,et al.  Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[3]  N. Bazan.  Lipid signaling in neural plasticity, brain repair, and neuroprotection , 2005, Molecular Neurobiology.

[4]  A. Mackinnon,et al.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. , 2010, Archives of general psychiatry.

[5]  S. Wood,et al.  Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial. , 2007, The Journal of clinical psychiatry.

[6]  M. Ron,et al.  The effect of chlorpromazine and methylprednisolone on NMR relaxation times in the normal cat brain , 1991, Magnetic resonance in medicine.

[7]  M. Lynch,et al.  Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation. , 2002, The Journal of biological chemistry.

[8]  S. Wood,et al.  Incipient neurovulnerability and neuroprotection in early psychosis. , 2003, Psychopharmacology bulletin.

[9]  Michael Berk,et al.  Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. , 2009, Annals of the Academy of Medicine, Singapore.

[10]  Rohit Bakshi,et al.  3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis , 2009, NeuroImage.

[11]  N. Bazan,et al.  Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. , 1995, Journal of neurotrauma.

[12]  A. Simmons,et al.  Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder , 2007, Journal of psychopharmacology.

[13]  A. Connelly,et al.  Quantitative neuropathology and quantitative magnetic resonance imaging of the hippocampus in temporal lobe epilepsy , 1997, Annals of neurology.

[14]  R. Grimble,et al.  The influence of membrane fluidity, TNF receptor binding, cAMP production and GTPase activity on macrophage cytokine production in rats fed a variety of fat diets , 2004, Molecular and Cellular Biochemistry.

[15]  M. Lynch,et al.  Neuroprotective Effect of Eicosapentaenoic Acid in Hippocampus of Rats Exposed to γ-Irradiation* , 2002, The Journal of Biological Chemistry.

[16]  A. Stoll,et al.  Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. , 2004, The American journal of psychiatry.